StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for SBC yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-19 | $2.87 | $2.89 | +0.70% | 0.2M |
| 05-20 | $2.86 | $3.23 | +12.94% | 0.2M |
| 05-21 | $3.21 | $3.10 | -3.43% | 0.1M |
| 05-22 | $3.11 | $3.07 | -1.29% | 0.1M |
| 05-26 | $3.08 | $3.12 | +1.30% | 0.1M |
SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). The firm generates revenue mostly from these management services.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $43.06M | $173.61M | $134.04M | $90.69M |
Operating Income | $17.72M | $67.49M | $54.64M | $38.76M |
Net Income | $11.31M | $50.99M | $36.79M | $23.96M |
EPS (Diluted) | $0.11 | $0.50 | $0.36 | $0.23 |
Total Assets | $388.02M | $380.45M | $321.36M | $315.30M |
Total Liabilities | $117.64M | $117.14M | $73.30M | $70.65M |
Cash & Equivalents | $167.31M | $163.77M | $127.43M | $152.74M |
Free Cash Flow OCF − CapEx | $9.11M | $23.27M | $-27.90M | $-6.97M |
Shares Outstanding | 102.58M | 102.58M | 102.58M | 103.10M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.